Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Dual-energy CT systems allow for significant reduction in contrast dose
DECT systems allow for a contrast dose reduction of up to 25% during computed tomography pulmonary angiography exams.
FDA to add ‘black box’ warning to COVID vaccines, report says
The label is the most serious warning the agency can place on pharmaceuticals, denoting substances that carry serious health risks that must be weighed against benefits. CNN was the first to report the news, citing two sources familiar with the matter.
FDA clears next-generation cardiac mapping software
San Diego-based Vektor Medical first secured FDA clearance for the AI-powered technology back in 2021. This updated announcement covers the latest version, which includes atrial flutter mapping and several other new features.
More interventional procedures may be coming to an ambulatory surgical center near you
ASCs have their limitations, but they are also associated with several benefits for cardiologists and patients alike.
New recalls announced for troubled heart devices—FDA previously urged customers to seek alternatives
These most recent recalls focus on a series of maintenance issues. In 2024, the FDA advised customers to transition away from the two devices and find alternative treatment options.

Beloved cardiologist Albert Waldo remembered for his lasting impact on electrophysiology

Waldo was a founding member of the North American Society of Pacing and Electrophysiology, which is now known as the Heart Rhythm Society, and was revered for his helpfulness and kindness.

Recor Medical's Paradise Ultrasound Renal Denervation System

FDA panel votes in favor of Recor Medical renal denervation system

A few members of the panel did question the device's efficacy and long-term durability. The FDA will now use these findings to make its final decision related to the system's approval.

Missed opportunities: Many high-risk patients still not taking aspirin to prevent CVD

Aspirin is known to be an effective, affordable way to prevent cardiovascular disease.

A TAVR procedure being performed at Northwestern Medicine in Chicago. These structural heart procedures require a team approach.

TAVR safe and effective for severe AS patients with a very low gradient

Yes, all-cause cause mortality is higher among TAVR patients with a very low baseline gradient, but the difference is almost entirely due to those patients presenting with more comorbidities.

Video of ASE President Stephen Little, MD, discussing trends in interventional echo at the ASE 2023 annual meeting.

Interventional echocardiography expected to grow thanks to new structural heart procedures

American Society of Echocardiography (ASE) President Stephen Little, MD, says there will be an increasing need for interventional echocardiographers in the near future.

cardiologist doctor physician patient black diverse hypertension

Chest pain one year after a heart attack linked to lower odds of survival

A new study in the Journal of the American Heart Association focused on data from more than 18,000 patients.

device implantation during left atrial appendage occlusion (LAAO) procedures

Mitigating risk: How the depth of device implantation impacts LAAO outcomes

Researchers examined data from more than 1,300 procedures, presenting their findings in JACC: Cardiovascular Interventions.

A complete list of the European Society of Cardiology (ESC) 2023 Congress late-breaking Hot Line sessions. #ESCCongress

ESC Congress 2023 to feature 30 late-breaking clinical trials

The European Society of Cardiology's annual meeting is scheduled for Aug. 25-28, 2023, in Amsterdam.

Clinical

Dual-energy CT systems allow for significant reduction in contrast dose

FDA to add ‘black box’ warning to COVID vaccines, report says

FDA clears next-generation cardiac mapping software

More interventional procedures may be coming to an ambulatory surgical center near you

New recalls announced for troubled heart devices—FDA previously urged customers to seek alternatives